HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

desazadesferrithiocin

structure in first source

Also Known As:

(-)-(R)-2-(2,4-dihydroxyphenyl)-4,5-dihydro-4-methyl-4-thiazolecarboxylic acid (4'-hydroxydesazadesferrithiocin)

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - desazadesferrithiocin: 1
  - Pyridines: 88
    - Dihydropyridines: 214
      - desazadesferrithiocin: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - desazadesferrithiocin: 1

Experts

1.	Clark, Martha A: 1 article (01/2012)
2.	Ferrer, Patricia: 1 article (01/2012)
3.	Hand, Carla Cerami: 1 article (01/2012)
4.	Rienhoff, Hugh Young: 1 article (01/2012)
5.	Sullivan, David J: 1 article (01/2012)
6.	Tripathi, Abhai K: 1 article (01/2012)

Related Diseases

1.	Iron Overload 01/01/2012 - "FBS0701, (S)3"-(HO)-desazadesferrithiocin-polyether [DADFT-PE], is an oral iron chelator currently in Phase 2 human studies for the treatment of transfusional iron overload. "

Related Drugs and Biologics

1.	Iron
2.	Chelating Agents
3.	4,5- dihydro- 2- (2- hydroxy- 3- (3,6,9- trioxadecyloxy)phenyl)- 4- methyl- 4- thiazolecarboxylic acid